Search This Blog

Thursday, September 13, 2018

Cara Therapeutics initiated at Jefferies


Cara Therapeutics initiated at Jefferies  Cara Therapeutics initiated with a Buy at Jefferies. analyst Matthew Andrews started Cara Therapeutics with a Buy rating and $30 price target.
https://thefly.com/landingPageNews.php?id=2789751
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)